Is irisin an early marker of statin-induced myopathy? Bench to the bedside

Author： Pothineni Naga Venkata   Ding Zufeng   Mehta Jawahar L  

Publisher： Future Medicine

ISSN： 1758-4299

Source： Clinical Lipidology, Vol.8, Iss.6, 2013-12, pp. : 623-625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of mitochondria in statin‐induced myopathy

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 7, 2015-07 ,pp. : 745-754

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atorvastatin Metabolite Measurements as a Diagnostic Tool for Statin-Induced Myopathy

By Skottheim Ine B.  

Molecular Diagnosis & Therapy, Vol. 15, Iss. 4, 2011-08 ,pp. : 221-227

Adis International

Access to resources Recommend Favorite

Anti‐HMGCR autoantibodies in self‐limiting statin‐induced myopathy

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 12, 2017-12 ,pp. : 2179-2181

John Wiley & Sons Inc

Access to resources Recommend Favorite

Statin‐induced Myopathy and Ubiquinone Levels in Serum – Results from a Prospective, Observational Study

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 2, 2015-08 ,pp. : 133-136

John Wiley & Sons Inc

Access to resources Recommend Favorite

SLCO1B1 Genetic Variant Associated With Statin‐Induced Myopathy: A Proof‐of‐Concept Study Using the Clinical Practice Research Datalink

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 6, 2013-12 ,pp. : 695-701

John Wiley & Sons Inc

Access to resources Recommend Favorite